As the world’s major political parties seek to promote a thermo-nuclear war to cover up their complicity in the injected genocide of humanity – here is a conspiracy hypothesis for more of the same
Hypothesis: The FDA/CDC have arranged with big pharma to replace the existing flu vaccine made using chicken eggs with mRNA based flu inoculation – possibly combined with three other shots as a trivalent inoculation (C19, RSV and flu) – for a cost of around 200 bucks a dose.
Here’s a link to the CDC page on how flu vaccines are made.
How Influenza (Flu) Vaccines Are Made | CDC
“Egg-Based Flu Vaccines
The most common way that flu vaccines are made is using an egg-based manufacturing process that has been used for more than 70 years. Egg-based vaccine manufacturing is used to make both inactivated (killed) vaccine (usually called the “flu shot”) and live attenuated (weakened virus) vaccine (usually called the “nasal spray flu vaccine”).
“The egg-based production process begins with CDC or another laboratory partner in the WHO Global Influenza Surveillance and Response System providing private sector manufacturers with candidate vaccine viruses (CVVs) grown in chicken eggs per current FDA regulatory requirements. These CVVs are then injected into fertilized chicken eggs and incubated for several days to allow the viruses to replicate.
The fluid containing virus is harvested from the eggs. For inactivated influenza vaccines (i.e., flu shots), the vaccine viruses are then inactivated (killed), and the virus antigen is purified. The manufacturing process continues with quality testing, packaging and distribution. For the nasal spray flu vaccine (i.e., the live attenuated influenza vaccine – LAIV), the starting CVVs are used to make live, but weakened viruses that are then used in vaccine production. FDA tests and approves all flu vaccines prior to release and shipment.”
The target market for the flu vaccines is here:
Weekly Flu Vaccination Dashboard | FluVaxView | Seasonal Influenza (Flu) | CDC
“For the 2023-24 season, as of March 9, 2024, 157.72 million doses of flu vaccine have been distributed in the United States. March 9, 2024, was the final update for doses distributed.”
There is no barrier to entry into the flu shot market as the existing flu shots have no clear benefit. H5N1 is being used as an excuse to kill hundreds of millions of chickens and plant the seed of distrust in an already ineffective flu vaccine, made with chicken eggs.
Th logic = “Chickens and their eggs are likely to be infected with a bird flu – you cannot make a flu vaccine using chicken eggs, the only alternative is mRNA inoculation”.
Since C19 inoculations are being declined (“nobody wants the steenking vaccines” sales need a massive boost to resurrect huge (lost) profits from idle production facilities - at the same time, whilst there is no medical need for a RSV injection, putting both C19 and RSV in the same mRNA shot will create the same sales (and profits) as there is for the existing egg-based flu shot - around 160 million shots a year – at a price of around 200 bucks for a trivalent shot
Targeted annual sales – maybe split in Moderna’s favour – 200 bucks times 160 million doses = 32 billion dollars annually. Knock on effects of treating the adverse events – at least double that.
Sound about right?
Onwards!!!
Please take a paid subscription or forward this article to those you think might be interested. You can also donate via Ko-fi – any amount from three dollars upwards. Ko-fi donations here: https://ko-fi.com/peterhalligan
There's also mammalian cell-based flu vaccines. Interestingly first tried at the same time that we were told a novel flu virus was emerging from Wuhan.
This publication describes a brand-new style of flu vaccine that came online for the 2019-2020 flu season. Mammalian cell-based instead of egg-based. Claims that it was studied for efficacy...but no mention of safety trials:
https://pharmaceutical-journal.com/article/news/first-cell-based-quadrivalent-vaccine-available-for-2019-2020-flu-season
"A new cell-based seasonal influenza vaccine has been issued marketing approval by the European Commission and will be available for the 2019/2020 flu season.
Flucelvax® Tetra (Seqirus) is the first cell-based quadrivalent influenza vaccine (QIVc) to be made available in Europe and is licensed for use in individuals aged nine years and older.
To date, there have been no randomised controlled trials comparing the efficacy of QIVc and standard egg-based quadrivalent vaccines (QIVe)"
“This real-world study, along with other emerging evidence, indicates that cell-based influenza vaccines may result in better influenza-related outcomes compared to standard egg-based vaccine options in some seasons"
"In the UK, the potential advantages of QIVc, which is cultured in mammalian cells rather than eggs"
“We are pleased to be bringing Flucelvax Tetra to the UK next season and have sufficient capacity at our cell-based manufacturing facility in the US to also ensure supply in September 2019"
.
This Is A Military Coup.
You Can Call It Covid.
Or You Can Call It What It Is:
A Military Coup.
They Took Out One President.
And Installed A Puppet.
.